Seeking an optimal eradication therapy for Helicobacter pylori infection
Version of Record online: 21 DEC 2011
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd
Journal of Gastroenterology and Hepatology
Volume 27, Issue 1, pages 7–9, January 2012
How to Cite
Miura, S. and Hokari, R. (2012), Seeking an optimal eradication therapy for Helicobacter pylori infection. Journal of Gastroenterology and Hepatology, 27: 7–9. doi: 10.1111/j.1440-1746.2011.06953.x
- Issue online: 21 DEC 2011
- Version of Record online: 21 DEC 2011
- Accepted for publication 6 October 2011.
- 4Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am. J. Gastroenterol. 2007; 102: 1808–25., ;Direct Link:
- 10Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Clin. Pharmacol. Ther. 2001; 69: 158–68., , et al.
- 11The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis. Am. J. Gastroenterol. 2006; 101: 1467–75., , , , .Direct Link:
- 15Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis. Am. J. Gastroenterol. 2006; 101: 488–96., , , .Direct Link:
- 19Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days. Helicobacter 2011; 16: 139–45., , , .
- 22Effectiveness of three-times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea. Br. J. Clin. Pharmacol. 2011 DOI: 10.1111/j.13652125.2011.04048X., , et al.
- 24The Chronic Otitis Media Intervention Trial-One (COMIT1) group. Compared to placebo, long-term antibiotics resolve otitis media with effusion (OME) and prevent acute otitis media with perforation (AOMwiP) in a high-risk population: a randomized controlled trial. BMC Pediatr. 2008; 8: 23., , ;